Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease

Background:Mucosal-associated invariant T (MAIT) cells are innate-like T cells involved in the homeostasis of mucosal immunity; however, their role in inflammatory bowel disease (IBD) is unclear. Methods:Flow cytometry was used to enumerate peripheral blood MAIT cells in 88 patients with ulcerative colitis (UC), 68 with Crohn's disease (CD), and in 57 healthy controls. Immunohistochemistry identified MAIT cells in intestinal tissue samples from patients with UC (n = 5) and CD (n = 10), and in control colon (n = 5) and small intestine (n = 9) samples. In addition, expression of activated caspases by MAIT cells in the peripheral blood of 14 patients with UC and 15 patients with CD, and 16 healthy controls was examined. Results:Peripheral blood analysis revealed that patients with IBD had significantly fewer MAIT cells than healthy controls (P < 0.0001). The number of MAIT cells in the inflamed intestinal mucosae of patients with UC and CD was also lower than that in control mucosae (P = 0.0079 and 0.041, respectively). The number of activated caspase-expressing MAIT cells in the peripheral blood of patients with UC and CD was higher than that in healthy controls (P = 0.0061 and 0.0075, respectively), suggesting that the reduced MAIT cell numbers in IBD are associated with an increased level of apoptosis among these cells. Conclusions:The number of MAIT cells in the peripheral blood and inflamed mucosae of patients with UC and CD was lower than that in non-IBD controls. Also, MAIT cells from patients with IBD exhibited proapoptotic features. These data suggest the pathological involvement and the potential for therapeutic manipulation of these cells in patients with IBD.

[1]  Ta-Chiang Liu,et al.  Genetics and Pathogenesis of Inflammatory Bowel Disease. , 2016, Annual review of pathology.

[2]  T. Hinks.  Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease. , 2015, Inflammatory Bowel Diseases.

[3]  Borislav D. Dimitrov,et al.  Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms , 2015, The Journal of allergy and clinical immunology.

[4]  E. Adams,et al.  The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity , 2015, Front. Immunol..

[5]  O. Lantz,et al.  Innate mucosal‐associated invariant T (MAIT) cells are activated in inflammatory bowel diseases , 2014, Clinical and experimental immunology.

[6]  A. Kaser,et al.  α4β7 integrin: beyond T cell trafficking , 2013, Gut.

[7]  P. Calabresi,et al.  Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. , 2013, Brain : a journal of neurology.

[8]  B. Gazzard,et al.  Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. , 2013, Blood.

[9]  A. Fischer,et al.  Human iNKT and MAIT cells exhibit a PLZF-dependent proapoptotic propensity that is counterbalanced by XIAP. , 2013, Blood.

[10]  G. Silvestri,et al.  Microbial Translocation in the Pathogenesis of HIV Infection and AIDS , 2013, Clinical Microbiology Reviews.

[11]  Malcolm J. McConville,et al.  MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.

[12]  P. Klenerman,et al.  Human MAIT and CD8αα cells develop from a pool of type-17 precommitted CD8+ T cells. , 2012, Blood.

[13]  H. Kanegane,et al.  Clinical and Genetic Characteristics of XIAP Deficiency in Japan , 2012, Journal of Clinical Immunology.

[14]  T. Yamamura,et al.  Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. , 2011, International immunology.

[15]  W. Strober,et al.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.

[16]  A. Fischer,et al.  Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). , 2011, Blood.

[17]  M. Smyth,et al.  Presumed guilty: natural killer T cell defects and human disease , 2011, Nature Reviews Immunology.

[18]  Tanja Woyke,et al.  Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. , 2011, The Journal of allergy and clinical immunology.

[19]  O. Lantz,et al.  Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. , 2011, Blood.

[20]  M. J. Broadhurst,et al.  IL-22+ CD4+ T Cells Are Associated with Therapeutic Trichuris trichiura Infection in an Ulcerative Colitis Patient , 2010, Science Translational Medicine.

[21]  A. Snow,et al.  X-linked lymphoproliferative syndromes: brothers or distant cousins? , 2010, Blood.

[22]  J. McCluskey,et al.  Fighting infection with your MAITs , 2010, Nature Immunology.

[23]  O. Lantz,et al.  Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.

[24]  D. Godfrey,et al.  Raising the NKT cell family , 2010, Nature Immunology.

[25]  T. Hibi,et al.  Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. , 2009, Gastroenterology.

[26]  O. Lantz,et al.  Stepwise Development of MAIT Cells in Mouse and Human , 2009, PLoS biology.

[27]  A. Murphy,et al.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.

[28]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[29]  T. Hibi,et al.  Lamina propria c-kit+ immune precursors reside in human adult intestine and differentiate into natural killer cells. , 2007, Gastroenterology.

[30]  G. Salvesen,et al.  Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family , 2006, EMBO reports.

[31]  M. Zeitz,et al.  Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. , 2005, Gastroenterology.

[32]  O. Lantz,et al.  Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subset. , 2005, Microbes and infection.

[33]  C. Neut,et al.  Dysbiosis as a prerequisite for IBD. , 2004, Gut.

[34]  P. Mannon,et al.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. , 2004, The Journal of clinical investigation.

[35]  C. Neut,et al.  Self inflicted rectal ulcer: hearing is believing , 2003, Gut.

[36]  Olivier Lantz,et al.  Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.

[37]  C. Elia,et al.  Expression of lymphocyte-endothelial receptor-ligand pairs, α4β7/MAdCAM-1 and OX40/OX40 ligand in the colon and jejunum of patients with inflammatory bowel disease , 1999, Gut.

[38]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[39]  S. Deventer,et al.  Altered expression of alpha 4 beta 7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. , 1997, Gut.

[40]  B. Rowlands,et al.  Significance of systemic endotoxaemia in inflammatory bowel disease. , 1995, Gut.

[41]  Ami,et al.  Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. , 1989, BMJ.

[42]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.

[43]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[44]  J. Wehkamp,et al.  Inflammatory bowel disease: an impaired barrier disease , 2012, Langenbeck's Archives of Surgery.

[45]  J. Mora,et al.  Specificity and plasticity of memory lymphocyte migration. , 2006, Current topics in microbiology and immunology.